Tech Company Financing Transactions
Qool Therapeutics Funding Round
Qool Therapeutics, based in Menlo Park, secured $8 million from BioPacific Ventures, BrilliMedical International and FundRx.
Transaction Overview
Company Name
Announced On
11/29/2017
Transaction Type
Venture Equity
Amount
$8,000,000
Round
Series A
Investors
Proceeds Purpose
The company will use its new funding to complete product development and lay the groundwork for first-in-human clinical trials of its system.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
1455 Adams Dr. 2014
Menlo Park, CA 94025
USA
Menlo Park, CA 94025
USA
Phone
Website
Email Address
Overview
Therapeutic hypothermia, or targeted temperature management, is a medically controlled 2-5 ºC reduction of patient body temperature slowing inflammation, cell damage, and reducing cell oxygen requirements.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Beverly Huss
Chief Technical Officer
Amir Belson
VP - R & D
Michael Horzewski
VP - Regulatory Affairs
Kim Tompkins
Browse more venture capital transactions:
Prev: 11/29/2017: Yottaa venture capital transaction
Next: 11/29/2017: BetterLesson venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to record tech company VC transactions. VC investment data records reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs